Board

Board

Andreas Kogelnik, MD, PhD received his MD from Emory University and his PhD in bioengineering from the Georgia Institute of Technology. He completed his residency in Internal Medicine and a Fellowship in Infectious Diseases at Stanford University. He remained at Stanford with NIH funding for his post-doctoral research and as a research scientist in microbiology, immunology, and bioinformatics with Dr. Ellen Jo Baron, Dr. Stanley Falkow, and Dr. Atul Butte, exploring host-response profiles in severely ill patients and data mining clinical and genomic data for translational applications. He has founded several companies and a non-profit each with a unique focus on improving the health care system through research and innovation.

Chris Burggraeve is a leading global marketer and entrepreneur. Over the last 23 years, he has built world-class marketing capabilities in developed, developing, and emerging markets. After initial experience in technology startups, he worked in brand management and general management for Procter & Gamble, the Coca-Cola Company, and Anheuser-Busch InBev, where he was Chief Marketing Officer for nearly 5 years. Additionally, Chris took on global industry leadership roles. Since 2008 he has been actively involved in the Brussels-based World Federation of Advertisers. He was elected WFA President in April 2010, and re-elected in March 2012. He has also served on the board of the Belgian-American Chamber of Commerce in New York since 2010. In 2012, he started running his own portfolio of ventures (in Turkey, New York City, and Silicon Valley); founded Vicomte LLC, his New York-based marketing and strategy consultancy (www.vicomte.com), and joined NYU Stern as Adjunct Faculty for Global Programs.

Ron Davis, PhD is a Professor of Biochemistry & Genetics and Director of the Stanford Genome Technology Center. Dr. Davis, with David Botstein, Mark Skolnick, and Ray White developed the method for constructing a genetic linkage map using restriction fragment length polymorphisms that led to the Human Genome Project. He is a consummate engineer-scientist and has spawned numerous patents and multiple companies from his work. He is a member of the National Academy of Sciences. He has authored hundreds of scientific papers and has received many prestigious scientific awards, most recently the Gruber Prize.

Allan May is a Director at Emergent Medical Partners and has been a Founder, Board member and/or CEO of multiple successful biotech and device start ups including AngstroVision, Athenagen, IntegriGen, NuGen Technologies, and Vascular Architects. He has held senior executive roles at two publicly-traded companies. In 2005, he co-founded the largest angel investment organization in the US—Life Science Angels—and currently serves as its Chair.

Daniel Peterson, MD is heralded as a pioneer in the understanding of neuro-immune diseases. Based in Nevada, he was involved in treating patients during the late 1980’s outbreak of ME/CFS when the illness was recorded in 259 patients in the Incline Village area. He helped found the Whittemore Peterson Institute for Neuro-Immune Disease in 2005 and resigned his role there in 2010. He received his MD degree from the University of Rochester and subsequently was an intern and resident at the University of Utah. He is a community physician and Medical Director of Sierra Internal Medicine.